|
Acquisition of |
![]() |
$225 million
September 2020
|
![]() |
Majority recap by |
![]() |
$125 million
April 2019
|
![]() |
Sale of stock and conditional sale to |
![]() |
$215 million + CVRs
February 2019
|
![]() |
Acquisition of generics business of |
![]() |
$1.05 billion
June 2017
|
September 2020
Torreya report provides a snapshot of the global pharmaceutical industry in September 2020 and compares it to the industry in 2015.
Click Here for Report Executive Summary | Full Report (PDF 38.3MB) | Slide Overview (PDF 6.2MB)